Research & Development
Technology Awards
Sysmex Received “2021 Japan Society of Clinical Chemistry Technology Award”
Sysmex Corporation received the 2021 Technology Award from the Japanese Society of Clinical Chemistry for the development of the OncoBEAM™ RAS CRC Kit.
The Technology Award of the Japanese Society of Clinical Chemistry is awarded to members of the Japan Society of Clinical Chemistry for research and development in the field of clinical chemistry.
The Technology Award of the Japanese Society of Clinical Chemistry is awarded to members of the Japan Society of Clinical Chemistry for research and development in the field of clinical chemistry.
| Title of the award: OncoBEAM™ RAS CRC Kit Development |
| Winners: Sysmex Corporation |
| Description of the invention: The OncoBEAM™ RAS CRC Kit is used to test samples of tumor-derived DNA (circulating tumor DNA, or ctDNA) suspended in the blood of colorectal cancer patients. To help doctors determine treatment methods, this product provides auxiliary test data to determine the appropriateness for patients with colorectal cancer of the molecularly targeted drugs—Cetuximab and Panitumumab (gene recombination) —, using BEAMing technology that detects RAS gene mutations to a high degree of sensitivity. Gene testing using this product can be used to provide appropriate treatment opportunities for patients who would have difficulty with testing using conventional tumor tissue. Furthermore, rather than physical biopsies, this type of testing allows samples to be obtained from blood samples in a simple and minimally invasive manner. This helps reduce the physical and mental burden on the patient, shortens the time required from the start of testing, and contributes to the early-stage determination of treatment methods. |
- Information contained in the technology awards is current as of the date of the announcement,
but may be subject to change without prior notice.